Mindset Pharma (MSSTF) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free MSSTF Stock Alerts $0.54 0.00 (0.00%) (As of 10/27/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesStock AnalysisHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCultivating a good mindset can lead to enhanced productivity – Nutritionistmsn.com - April 30 at 5:28 PMFTSE 100 chiefs claim they are hard-up compared with the States. But our analysis suggests a very different story: Are British bosses REALLY underpaid?msn.com - April 27 at 10:05 PMLive news: Police presence grows as pro-Palestine protests spread across US campusesft.com - April 26 at 9:01 PMNew Benevity data shows companies that embrace an 'impact mindset' are building resilience in a polarized worldtmcnet.com - April 25 at 9:57 AMNvidia: Significant Downside Risks As Its Customers Develop AI Chipsseekingalpha.com - April 22 at 3:00 PMMorocco's investments in Africa, an asset for the continentmsn.com - April 10 at 2:22 PMThe evolving field of software product management, how can working professionals react to it?msn.com - April 4 at 3:16 AM‘AI and aai sound similar’, PM Modi tells Bill Gatesmsn.com - March 29 at 11:46 PMSlow The Flow: 3 Ways Smart Leaders Decide In A Noisy Worldforbes.com - March 18 at 5:39 PMRonnie O'Sullivan leaves snooker legend in a quandary as Rocket aims to make more historymsn.com - March 15 at 9:12 PMAION Labs Launches CombinAble.AI to Reduce Time and Cost of Targeted Antibody Design, Advancing Optimization of Drug Developmenttmcnet.com - March 12 at 7:33 PMHow Mindset Builds The Foundation For Personal and Professional Success - A Look Through Shane Quigley's Lensbenzinga.com - March 6 at 6:19 PMSaving Telco From Itself: Overcoming The Top 5 Challenges In 2024forbes.com - February 28 at 10:44 AMQuite bullish and overweight on pharma stocks: Vikas Khemanimsn.com - February 8 at 3:16 AMQ1 2024 Becton Dickinson and Co Earnings Calluk.finance.yahoo.com - February 2 at 2:52 AMAlginates & Derivatives Market worth $651 million by 2028 - Exclusive Report by MarketsandMarkets™finance.yahoo.com - February 1 at 11:50 AMMindset Pharma Inc.: Mindset Pharma Announces Receipt of Final Orderfinanznachrichten.de - October 25 at 7:54 PMMindset Pharma Announces Receipt of Final Orderfinance.yahoo.com - October 25 at 7:54 PMMindset Pharma Inc.: Mindset Pharma Provides Clarifying Disclosure in Connection with Proposed Plan of Arrangementfinanznachrichten.de - October 5 at 8:13 PMMindset Pharma updates investors on Otsuka Pharmaceutical transactionproactiveinvestors.com - September 25 at 6:04 PMMindset Pharma Announces Mailing of Circular and Receipt of Interim Orderfinance.yahoo.com - September 22 at 8:45 PMMindset Pharma to be acquired by Otsuka Pharmaceutical in all-cash...proactiveinvestors.com - August 31 at 5:35 PMMindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutionsbenzinga.com - August 31 at 5:35 PMMindset Pharma Inc (MSET)investing.com - August 3 at 4:40 PMTerran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Applicationbenzinga.com - July 18 at 10:26 PMPsyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & Moremsn.com - July 4 at 1:11 PMUK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depressionmsn.com - June 27 at 6:29 PMMindset Pharma's Phase 2 psilocin prodrug study gets green light from UK regulatorsproactiveinvestors.com - June 24 at 8:49 AMMindset Pharma Inc.: Mindset Pharma Receives Approval for Phase II Clinical Trial Evaluating MSP-1014 for the Treatment of Major Depressive Disorderfinanznachrichten.de - June 22 at 2:26 PMMindset Pharma Receives Approval for Phase II Clinical Trial Evaluating MSP-1014 for the Treatment of Major Depressive Disorderfinance.yahoo.com - June 22 at 9:26 AMThree Ways To Unlock The Leader's Mindsetforbes.com - June 18 at 9:18 AMMindset Matters: The Changing Business Of Mental Health (Part Four)forbes.com - June 2 at 1:42 PM5 Mindset Roadblocks That Are Sabotaging Your Careerforbes.com - June 2 at 3:41 AMThis Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protectionmsn.com - April 26 at 5:51 PMMindset Pharma files two international patent applications under the Patent Cooperation Treatyproactiveinvestors.com - April 26 at 12:44 PMMindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compoundsfinance.yahoo.com - April 26 at 7:44 AMMindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeuticsfinance.yahoo.com - April 6 at 4:38 PMMindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023finance.yahoo.com - April 6 at 4:38 PM Get Mindset Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MSSTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. MSSTF Media Mentions By Week MSSTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MSSTF News Sentiment▼0.880.42▲Average Medical News Sentiment MSSTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MSSTF Articles This Week▼10▲MSSTF Articles Average Week Get Mindset Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MSSTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MSSTF) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mindset Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
